Resources from the same session
Adjuvant CDK inhibitors: The new treatment paradigm for high risk HR+HER2- breast cancer
Presenter: Joseph Gligorov
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
Can novel endocrine agents optimise adjuvant therapy further?
Presenter: Patrick Neven
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
Extended adjuvant chemotherapy for luminal cancers
Presenter: Masakazu Toi
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast
Other potential adjuvant strategies for high-risk HR+HER2- breast cancer
Presenter: Yoon Sim Yap
Session: New adjuvant strategies for luminal cancers
Resources:
Slides
Webcast